Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy-Reference-Cited by-同舟云学术

Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy

Published:2006-06 Issue:3 Volume:20 Page:539-557
ISSN:1521-6942
Container-title:Best Practice & Research Clinical Rheumatology
language:en
Short-container-title:Best Practice & Research Clinical Rheumatology

Author:

Akkoc Nurullah,van der Linden Sjef,Khan Muhammad Asim

Publisher

Elsevier BV

Subject

Rheumatology

Reference96 articles.

1. Update on spondyloarthropathies;Khan;Annals of Internal Medicine,2002

2. Spondyloarthropathies. Ankylosing spondylitis;van der Linden,2004

3. Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review;Boonen;The Journal of Rheumatology,2001

4. Functional disability predicts total costs in patients with ankylosing spondylitis;Ward;Arthritis and Rheumatism,2002

5. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries;Boonen;Annals of the Rheumatic Diseases,2002

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational linguistics and sentiment analysis of misconceptions in pharmacotherapy of osteoarthritis pain;Epilepsy and paroxysmal conditions;2023-09-28

2. Sulfasalazine promotes myogenic differentiation via increasing of fast myosin heavy chain isoforms;2023-08-16

3. Differentially expressed protein‐coding genes in ankylosing spondylitis: Emerging insights into pathogenesis and therapeutic approaches;International Journal of Rheumatic Diseases;2023-07-05

4. From misconceptions to reasonable osteoarthritis patients therapy;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-06-07

5. Microorganisms in the Pathogenesis and Management of Ankylosing Spondylitis;Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases;2022